Skip to main content
. 2017 Feb 1;9(3):263–275. doi: 10.1177/1947603517693043

Table 2.

Level of Consensus on Retreatment after Success of Viscosupplementation.

Issues on Retreatment after Success of Viscosupplementation Level of Consensus Agreement
Agree Disagree
Retreatment with VS must be considered
 Systematically every 6-12 months, even if patients remain asymptomatic Strongly against 2 8
 Only if pain returns to pretreatment levels Strong against 2 8
 Only from a certain level of pain (i.e., PASS) Strongly in favor 8 2
 As soon as pain occurs again Strongly in favor 9 1
 According to the patient’s wishes Moderately in favor 7 3
Must we retreat systematically little symptomatic patients?
 Yes Weakly in favor 6 4
 Every 3 months Strongly against 0 6
 Every 6 months Strongly against 1 5
 Every year Strongly against 1 5
 Yes but the time interval between 2 treatments must be adapted to the patient’s situation (i.e., age, anatomical severity, activities, etc.) Unanimously in favor 6 0
Which of these clinical situations may push you into retreating patients?
 Early stage of OA? Strongly in favor 9 1
 Advanced stage of OA? Strongly against 2 8
 Young age? Strongly in favor 9 1
 Elderly Moderately against 3 7
 Risk factors of rapid progression? Strongly in favor 9 1
 Sports practice (leisure)? No consensus 5 5
 Sports practice (professional)? Strongly in favor 9 1
 Contraindication to arthroplasty? Moderately in favor 7 3
 Severe comorbidities? Strongly in favor 8 2
Does the chondroprotective properties of HA influence your decision to retreat asymptomatic or little symptomatic patients with HA? Strongly in favor 8 2

VS = viscosupplementation; OA = osteoarthritis; PASS = Patient’s Acceptable Symptom State; HA = hyaluronic acid.